Axelsson Sara, Lindberg Sven, Stjernquist-Desatnik Anna
Department of Otorhinolaryngology-Head and Neck Surgery, Hospital of Helsingborg, Helsingborg, Sweden.
Ann Otol Rhinol Laryngol. 2003 Mar;112(3):197-201. doi: 10.1177/000348940311200301.
Idiopathic facial paralysis, or Bell's palsy, shows a nonepidemic pattern that might indicate reactivation of a latent microorganism such as herpes simplex type I as a causative agent. Thirty percent of patients with Bell's palsy given no treatment will not recover completely, and 5% will have severe sequelae. The aim of this study was to find out whether treatment with an antiviral drug in combination with corticosteroids is more effective than no medical treatment at all in patients with Bell's palsy. Fifty-six consecutive adult patients attending the otorhinolaryngology department of the University Hospital of Lund from 1997 to 1999 were treated with 1 g of valacyclovir hydrochloride 3 times per day for 7 days and 50 mg of prednisone daily for 5 days, with the dose being reduced by 10 mg daily for the next 5 days. Fifty-six adult patients with Bell's palsy attending the same department between 1995 and 1996 who were given no medical treatment were studied retrospectively and used as the control group. Forty-nine patients (87.5%) in the treatment group recovered completely, as compared with 38 patients (68%) in the control group (p < .05). One patient (1.8%) in the treatment group displayed severe sequelae, defined as a House-Brackmann score of IV or worse, as compared with 10 of 56 patients (18%) in the control group (p < .01). Among patients over 60 years old, 10 of 10 in the treatment group had complete recovery, as compared with 5 of 12 patients in the control group (p < .01). The present study showed a significantly better outcome in patients with Bell's palsy treated with valacyclovir and prednisone as compared with patients given no medical treatment. This difference in outcome was especially pronounced among elderly patients.
特发性面神经麻痹,即贝尔面瘫,呈现非流行模式,这可能表明潜伏微生物(如I型单纯疱疹病毒)作为病原体被重新激活。30%未经治疗的贝尔面瘫患者无法完全康复,5%会出现严重后遗症。本研究的目的是探究在贝尔面瘫患者中,抗病毒药物联合皮质类固醇治疗是否比完全不进行药物治疗更有效。1997年至1999年期间,连续56名在隆德大学医院耳鼻喉科就诊的成年患者接受了治疗,他们每天服用3次1克盐酸伐昔洛韦,共7天,每日服用50毫克泼尼松,共5天,接下来5天每天剂量减少10毫克。对1995年至1996年期间在同一科室就诊且未接受任何药物治疗的56名成年贝尔面瘫患者进行回顾性研究,并将其作为对照组。治疗组中有49名患者(87.5%)完全康复,而对照组中有38名患者(68%)完全康复(p <.05)。治疗组中有1名患者(1.8%)出现严重后遗症,定义为House-Brackmann评分IV级或更差,而对照组56名患者中有10名(18%)出现严重后遗症(p <.01)。在60岁以上的患者中,治疗组10名患者中有10名完全康复,而对照组12名患者中有5名完全康复(p <.01)。本研究表明,与未接受药物治疗的患者相比,接受伐昔洛韦和泼尼松治疗的贝尔面瘫患者预后明显更好。这种预后差异在老年患者中尤为明显。